Trophos

Trophos is a late stage clinical company with a pipeline of original molecules in development for neurological and cardiac diseases. Read more

Christine Placet's photo - CEO of Trophos

CEO

Christine Placet

CEO Approval Rating

68/100

Founded:

06/1999

Est. Annual Revenue
Est. Employees
Sector

Update Industry

TROPHOS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Innate Pharma is a top competitor of Trophos. Innate Pharma was founded in 1999, and is headquartered in Marseille, Provence-Alpes-Côte-d'Azur. Innate Pharma is in the Biotechnology industry. Innate Pharma generates $79.4M more revenue vs. Trophos.

TxCell is seen as one of Trophos's top competitors. TxCell is headquartered in Valbonne, Provence-Alpes-Côte-d'Azur, and was founded in 2001. TxCell is in the Biotechnology field. TxCell generates ∞% the revenue of Trophos.

Transgene has been one of Trophos's top competitors. Transgene's headquarters is in Strasbourg, Other, and was founded in 1979. Transgene competes in the Biotechnology industry. Transgene generates ∞% of Trophos's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is bluebird bio a competitor of Trophos?

Trophos Acquisitions

No recent acquisitions found related to Trophos

Trophos Funding History

Since Trophos was founded in 06/1999, it has participated in 1 round of funding. In total Trophos has raised $11.6M. Trophos' funding round was on Sep 2007 for a total of $11.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series C
Sep 2007
$11.6M
-

Since Trophos was founded in 06/1999, it has participated in 1 round of funding. In total Trophos has raised $11.6M. Trophos' funding round was on Sep 2007 for a total of $11.6M

Trophos Investments

No recent investments found related to Trophos

Trophos News

April 8, 2014BIO PORTFOLIO

Trophos announces topline results in pivotal trial of Olesoxime in spinal muscular atrophy

Promising results for the maintenance of motor function in spinal muscular atrophy SMA a rare serious... See more »
March 11, 2014BIOCENTURY

Trophos reports data for muscular atrophy compound

Trophos S.A. (Marseille, France) said once-daily oral olesoxime (TRO19622) prevented loss of motor fu... See more »

Trophos Press Releases

Social Media

Trophos Headquarters

Parc scientifique de Luminy Case 931

Marseille Cedex 9, Other13288

33-0-491-828-282

Driving Directions »

Trending Companies

Trophos Summary

ABOUT

Overview

Trophos is a late stage clinical company with a pipeline of original molecules in development for neurological and cardiac diseases. Trophos was founded in 06/1999. Trophos' headquarters is located in Marseille Cedex 9, Other, FR 13288. It has raised ...

CEO

Trophos's CEO, Christine Placet, currently has an approval rating of 68%. Trophos's primary competitors are Innate Pharma, TxCell & Transgene.

Frequently Asked Questions about Trophos

  1. When was Trophos founded?

    Trophos was founded in 06/1999
  2. Who is Trophos's CEO?

    Trophos's CEO is Christine Placet
  3. How much revenue does Trophos generate?

    Trophos generates $ < 1M in revenue
  4. How much funding does Trophos have?

    Trophos has historically raised $11.6M in funding
  1. Where is Trophos's headquarters?

    Trophos's headquarters is in Marseille Cedex 9 Other, FR
  2. How many employees does Trophos have?

    Trophos has 40 employees
  3. Who are Trophos's competitors?

    Trophos's top competitors are Innate Pharma, TxCell, Transgene